Augustine Lawlor's Net Worth

$89.4 Million

Estimate Recalculated Apr 19, 2024 03:33PM EST

Who is Augustine Lawlor?

Augustine Lawlor has an estimated net worth of $89.4 Million. This is based on reported shares across multiple companies, which include PHARMATHENE, INC, CRITICAL THERAPEUTICS INC, ADVANCIS PHARMACEUTICAL CORP, ACTIVBIOTICS INC, TETRALOGIC PHARMACEUTICALS Corp, Radius Health, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., THRESHOLD PHARMACEUTICALS INC, GLOBEIMMUNE INC, MEMORY PHARMACEUTICALS CORP, LEAP THERAPEUTICS, INC., Cardiovascular Systems Inc, CATALYST BIOSCIENCES, INC., and HUMAN GENOME SCIENCES INC.

SEC CIK

Augustine Lawlor's CIK is 0001262327

Past Insider Trading and Trends

2007 was Augustine Lawlor's most active year for acquiring shares with 15 total transactions. Augustine Lawlor's most active month to acquire stocks was the month of July. 2016 was Augustine Lawlor's most active year for disposing of shares, totalling 25 transactions. Augustine Lawlor's most active month to dispose stocks was the month of January. 2017 saw Augustine Lawlor paying a total of $6,436,524.37 for 2,462,417 shares, this is the most they've acquired in one year. In 2014 Augustine Lawlor cashed out on 26,062,394 shares for a total of $10,132,641.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TETRALOGIC PHARMACEUTICALS Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.59M
$7.00
$6,913,946.14
2.59M
Dec 17
Form 3
—
0
—
—
0
No matching records found

Radius Health, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 18 - Dec 14
Form 3
—
0
—
—
0
No matching records found

PHARMATHENE, INC (ALT) Snapshot price: $10.345

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+28.21%
935.81K
$2.54
$2,378,558.44
4.25M
Nov 3
Form 4
—
0
—
—
0
Jul 28
Form 4/A
+2,553.79%
3.19M
$7.66
$957,500.00
3.32M
Aug 3
Form 4
+2,537.74%
3.17M
$7.66
$957,500.00
3.3M
Aug 3
Form 3
—
0
—
—
0
No matching records found

TREVENA INC (TRVN) Snapshot price: $0.577

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.45M
$7.00
$2,079,406.00
2.45M
Feb 5
Form 3
—
0
—
—
0
No matching records found

PROTEOSTASIS THERAPEUTICS, INC. (KA) Snapshot price: $2.66

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.15M
$8.00
—
2.15M
Feb 17
Form 3
—
0
—
—
0
No matching records found